Skip to main content
logo
Coeptis Therapeutics Holdings, Inc. (COEP)
Apr 24, 2026 - COEP merged into ZSQR
16.40
+0.19 (1.17%)
Inactive · Last trade price on Apr 24, 2026

COEP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
102761127302,494
Market Cap Growth
193.85%572.97%-57.71%-10.53%-98.80%637.84%
Enterprise Value
96721226262,497
Last Close Price
-14.255.5015.6830.63200.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
74.8855.83---33258.23
PB Ratio
6.955.412.9232.856.711061.15
P/TBV Ratio
8.076.028.7932.856.711061.15

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
70.7952.53---33296.44

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.361.500.461.74
Net Debt / Equity Ratio
-0.28-0.430.22-0.30-0.390.81
Net Debt / EBITDA Ratio
0.420.51-0.100.010.05-0.14
Net Debt / FCF Ratio
0.620.71-0.130.030.45-0.42
Asset Turnover
0.090.11---0.02
Quick Ratio
2.903.600.120.511.750.79
Current Ratio
3.254.160.230.591.810.79
Return on Equity (ROE)
-102.85%-136.91%-464.73%-807.49%-1104.48%-
Return on Assets (ROA)
-48.52%-65.05%-93.24%-215.14%-291.15%-248.47%
Return on Capital Employed (ROCE)
-71.80%-90.70%-228.80%-1358.10%-595.40%-351.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.68%-15.66%-94.45%-79.54%-125.73%-0.54%
FCF Yield
-8.43%-11.30%-58.80%-27.08%-12.97%-0.18%
Buyback Yield / Dilution
-120.03%-120.03%-49.84%-79.70%-30.98%-79.11%
SEC Filings: 10-K · 10-Q